ORSO, BEATRICE
 Distribuzione geografica
Continente #
EU - Europa 2.282
AS - Asia 44
SA - Sud America 7
NA - Nord America 1
Totale 2.334
Nazione #
IT - Italia 2.281
CN - Cina 33
BR - Brasile 6
SG - Singapore 5
VN - Vietnam 4
AR - Argentina 1
HK - Hong Kong 1
ID - Indonesia 1
IE - Irlanda 1
US - Stati Uniti d'America 1
Totale 2.334
Città #
Genoa 1.437
Vado Ligure 310
Genova 297
Rapallo 208
Bordighera 23
Beijing 13
Singapore 3
Turin 3
Ashburn 1
Barreiros 1
Bắc Ninh 1
Cotia 1
Dublin 1
Hanoi 1
Ho Chi Minh City 1
Hong Kong 1
Malacacheta 1
Medan 1
Pouso Alegre 1
Reconquista 1
Rio das Ostras 1
Rome 1
Serra 1
Totale 2.309
Nome #
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 136
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 121
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 114
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 113
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 113
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 108
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 105
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 101
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 100
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 83
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 81
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 80
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 79
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 76
Multi-modal Imaging and Cognitive Profiles in de novo Parkinson’s Disease 76
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 75
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 72
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 71
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 69
How can we define a brain health chart? A narrative review and a proposal 63
null 63
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 59
Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients 59
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 55
Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy 53
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in~de~novo Parkinson's Disease 51
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies 43
Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort 37
Phase and amplitude EEG correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder 33
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease 27
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 26
Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson's Disease 23
Right posterior hypometabolism in Pisa syndrome of Parkinson's disease: A key to explain body schema perception deficit? 23
Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study 16
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 15
Unveiling Cortical Criticality Changes along the Prodromal to the Overt Continuum of Alpha-Synucleinopathy 6
The Many Faces of REM Sleep Behavior Disorder. Providing Evidence for a New Lexicon 3
Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum 2
Totale 2.430
Categoria #
all - tutte 11.346
article - articoli 11.017
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 6 33 4 14 11 9 4
2021/2022211 5 0 2 8 12 9 5 29 24 57 26 34
2022/2023247 14 21 4 22 27 25 0 17 41 19 47 10
2023/2024266 16 18 3 39 19 34 35 22 16 14 16 34
2024/2025913 31 51 23 69 75 113 101 157 45 58 84 106
2025/2026648 251 98 134 165 0 0 0 0 0 0 0 0
Totale 2.430